Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · View financials
Decision snapshot: EBS stock price vs DBI: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at DBI's multiple
Needs DBI P/E.
Implied fair value · at EBS's multiple
Needs EPS (TTM) is negative, EBS P/E.
Live quote
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: EBS FY 2025 (ended Dec 31, 2025) · DBI FY 2026 (ended Jan 31, 2026). Fiscal years are not aligned.
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
EMERGENT BIOSOLUTIONS INC. · implied price per share
Bear
$33.45
Base
$39.35
Bull
$45.26
DESIGNER BRANDS INC. · implied price per share
Bear
-$9.33
Base
-$10.97
Bull
-$12.62
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
1.92x
1.54x
Net debt / EBITDA
Leverage against operating earnings
2.45x
4.49x
Cash and equivalents
Liquid reserves on the balance sheet
$205.40M
$75.85M
Total debt
Interest-bearing obligations outstanding
$1.00B
$434.96M
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Moderna, Inc.
EBS vs MRNA
SIGA TECHNOLOGIES INC
EBS vs SIGA
Amphastar Pharmaceuticals, Inc.
EBS vs AMPH
CATALYST PHARMACEUTICALS, INC.
EBS vs CPRX
Organon & Co.
EBS vs OGN
PERRIGO Co plc
EBS vs PRGO
FOOT LOCKER, INC.
EBS vs FL
TJX COMPANIES INC /DE/
EBS vs TJX
Macy's, Inc.
EBS vs M
SHOE CARNIVAL INC
EBS vs SCVL
GENESCO INC
EBS vs GCO
WOLVERINE WORLD WIDE INC /DE/
EBS vs WWW
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
